Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy CEO & President bought 1,968,504 shares at $0.03 ($50,000)
  2. 4 Open-market buy Director bought 1,968,504 shares at $0.03 ($50,000)
  3. 4 Open-market buy CEO & President bought 41,000 shares at $0.06 ($2,583)
  4. 4 Open-market buy COO, Secretary, Gen. Counsel bought 500 shares at $0.09 ($44)
  5. 4 Grant or award Director acquired 44,899 shares (grant or award)
  6. 4 Grant or award Director acquired 44,899 shares (grant or award)
  7. 4 Grant or award Director acquired 44,899 shares (grant or award)
  8. 4 Open-market buy CEO & President bought 50,000 shares at $0.13 ($6,730)
  9. 4 Open-market buy CEO & President bought 44,000 shares at $0.12 ($5,060)
  10. 4 Grant or award Director acquired 19,290 shares (grant or award)
  11. 4 Grant or award Director acquired 38,580 shares (grant or award)
  12. 4 Grant or award Director acquired 38,580 shares (grant or award)
  13. 4 Open-market buy CEO & President bought 83,334 shares at $0.12 ($10,000)
  14. 3 Insider Initial Statement of Ownership
  15. 4/A Grant or award Director acquired 27,412 shares (grant or award)
  16. 4/A Grant or award Director acquired 43,330 shares (grant or award)
  17. 4/A Grant or award Director acquired 25,797 shares (grant or award)
  18. 4 Grant or award Director acquired 43,330 shares (grant or award)
  19. 4 Grant or award Director acquired 43,330 shares (grant or award)
  20. 4 Grant or award Director acquired 25,797 shares (grant or award)

Page 2 of 31 · 614 filings